Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MultiGFR: Calcium-EDTA and Gd-DOTA for GFR Measurement
NCT02286258Phase 2Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of edetate calcium disodium, gadoterate meglumine in chronic kidney disease (CKD), sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2014; status: terminated.
02
Drugs
edetate calcium disodiumgadoterate meglumine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02286258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02286258.